Trevi Therapeutics Inc (OQ:TRVI)

Business Focus: Bio Therapeutic Drugs

Jun 18, 2019 12:05 pm ET
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced that Company management will...
Jun 13, 2019 12:09 pm ET
Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced financial results for the...
May 07, 2019 09:22 am ET
Trevi Therapeutics Announces Pricing of Initial Public Offering
Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced the pricing of its initial public...